Hypotonic, Acidic Oxidizing Solution Containing Hypochlorous Acid (HClO) as a Potential Treatment of Hailey-Hailey Disease.
Acids
/ chemistry
Antioxidants
/ metabolism
Calcium-Transporting ATPases
/ metabolism
Cell Line
Cytokines
/ genetics
Gene Expression Regulation
/ drug effects
Humans
Hypochlorous Acid
/ pharmacology
Hypotonic Solutions
/ pharmacology
Keratinocytes
/ drug effects
NF-E2-Related Factor 2
/ metabolism
Oxidation-Reduction
Oxidative Stress
/ drug effects
Pemphigus, Benign Familial
/ drug therapy
Reactive Oxygen Species
/ metabolism
Solutions
Wound Healing
/ drug effects
Hailey–Hailey disease
keratinocytes
oxidative-stress
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
04 Dec 2019
04 Dec 2019
Historique:
received:
01
10
2019
revised:
29
11
2019
accepted:
02
12
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
13
5
2020
Statut:
epublish
Résumé
Hailey-Hailey disease (HHD) is a rare, chronic and recurrent blistering disorder, characterized by erosions occurring primarily in intertriginous regions and histologically by suprabasal acantholysis. Mutation of the Golgi Ca
Identifiants
pubmed: 31817098
pii: molecules24244427
doi: 10.3390/molecules24244427
pmc: PMC6943548
pii:
doi:
Substances chimiques
Acids
0
Antioxidants
0
Cytokines
0
Hypotonic Solutions
0
NF-E2-Related Factor 2
0
NFE2L2 protein, human
0
Reactive Oxygen Species
0
Solutions
0
Hypochlorous Acid
712K4CDC10
ATP2C1 protein, human
EC 7.2.2.10
Calcium-Transporting ATPases
EC 7.2.2.10
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Cell Calcium. 2008 Feb;43(2):105-6
pubmed: 17707506
J Dermatol Sci. 1998 Jul;17(3):167-81
pubmed: 9697045
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5068-72
pubmed: 1375756
J Invest Dermatol. 2002 Feb;118(2):338-43
pubmed: 11841554
Arch Dermatol. 2011 Feb;147(2):211-5
pubmed: 21339448
Adv Wound Care (New Rochelle). 2013 Jun;2(5):225-237
pubmed: 24761336
J Dermatol Sci. 2003 Oct;33(1):7-16
pubmed: 14527734
Pflugers Arch. 2003 May;446(2):148-53
pubmed: 12739151
Adv Wound Care (New Rochelle). 2013 Jun;2(5):195-214
pubmed: 24527343
Leukemia. 2015 Dec;29(12):2442-5
pubmed: 25982911
Clin Exp Dermatol. 2014 Mar;39(2):168-75
pubmed: 24256215
J Clin Invest. 1996 Jul 15;98(2):336-44
pubmed: 8755642
J Clin Invest. 1992 Aug;90(2):482-7
pubmed: 1644919
Wounds. 2014 Dec;26(12):342-50
pubmed: 25785777
Oncogene. 1998 Jul 9;17(1):25-34
pubmed: 9671311
J Am Acad Dermatol. 1994 Apr;30(4):535-46
pubmed: 7512582
Br J Dermatol. 2010 Mar;162(3):518-26
pubmed: 19903178
Br J Dermatol. 1992 Mar;126(3):275-82
pubmed: 1554604
Fibrogenesis Tissue Repair. 2008 Oct 13;1(1):5
pubmed: 19014652
J Invest Dermatol. 2004 Jul;123(1):124-31
pubmed: 15191552
Oxid Med Cell Longev. 2016;2016:5679040
pubmed: 26798423
Biochim Biophys Acta. 2016 Nov;1863(11):2650-2657
pubmed: 27523793
Exp Dermatol. 2012 Aug;21(8):586-91
pubmed: 22639968
Toxicol Appl Pharmacol. 2008 Feb 1;226(3):236-43
pubmed: 17980396
Clin Cosmet Investig Dermatol. 2016 Sep 14;9:281-290
pubmed: 27695354
J Leukoc Biol. 2003 Jun;73(6):713-21
pubmed: 12773503
J Biol Chem. 2007 Sep 7;282(36):26517-27
pubmed: 17597066
Sci Rep. 2016 Aug 16;6:31567
pubmed: 27528123
Adv Wound Care (New Rochelle). 2014 Jul 1;3(7):445-464
pubmed: 25032064
Exp Dermatol. 2011 Nov;20(11):932-7
pubmed: 21913998
Exp Dermatol. 1997 Apr;6(2):98-104
pubmed: 9209892
Int J Burns Trauma. 2012;2(1):18-28
pubmed: 22928164